Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Inactivated Influenza A/H5N1 Vaccine Administered Intradermally With or Without Topical Aldara in Healthy Young Adults
Conditions: Avian Influenza; Influenza Immunisation Interventions: Other: Aqueous Cream B.P.; Drug: Imiquimod; Biological: Influenza Virus Vaccine, Monovalent A/H5N1 A/Vietnam/1203/04 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Clinical Trials | H5N1 | Infectious Diseases | Influenza | Influenza Vaccine | Research | Vaccines | Vietnam Health